The Genomic Biomarkers Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Genomic Biomarkers Market?
The Genomic Biomarkers Global Market Report 2025 indicates a rapid growth trend in the genomic biomarkers market size. The market size expanded from $7.42 billion in 2024 and is projected to increase to $8.72 billion in 2025. This growth signifies a compound annual growth rate (CAGR) of 17.4%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Genomic Biomarkers Industry?
The Genomic Biomarkers Global Market Report 2025 projects that the market will expand to $16.51 billion by 2029, growing at a compound annual growth rate (CAGR) of 17.3%.
Download Your Free Sample of the 2025 Genomic Biomarkers Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Genomic Biomarkers Market?
The key drivers in the genomic biomarkers market are:
• Rising cases of ovarian and gastric cancer
• Growing acceptance and awareness of genetic testing
• Enhanced use of genomic biomarkers in cancer diagnosis and treatment
• Increasing adoption of companion diagnostics.
Global Market Segmentation: Identifying Major Genomic Biomarkers Industry Segments
The genomic biomarkersmarket covered in this report is segmented –
1) By Type: Predictive Biomarkers, Prognostic Biomarkers
2) By Disease Indication: Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, Other Disease Indications
3) By Validation: Analytical Validation, Clinical Validation, Clinical Utility
4) By End-User: Hospitals, Diagnostic Centers, Other End User
Pre-order the 2025 Genomic Biomarkers Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Genomic Biomarkers Market?
The key trends in the genomic biomarkers market are:
• There is a growing trend towards the use of Next-Generation Sequencing (NGS) in the genomic biomarkers market.
• Integration with other Omics technologies is being increasingly adopted in the market.
• Genomic technological advancements are significantly shaping the future of the market.
• Product innovations and advanced healthcare services are emerging trends in the genomic biomarkers market.
Who Are the Top Competitors & Leading Players in the Genomic Biomarkers Market?
Major companies in the genomic biomarkers market are:
• Thermo Fisher Scientific Inc.
• Roche Diagnostics International Ltd.
• Illumina Inc.
• PerkinElmer Inc.
• Almac Group
• Azenta Inc.
• Novogene Corporation
• Oxford Nanopore Technologies Ltd.
• Celerion
• Quanterix Corporation
• Bio-Rad Laboratories Inc.
• NantHealth Inc.
• Centogene N.V.
• Sophia Genetics SA
• Envisagenics
• Deep Genomics
• Creative Diagnostics
• Macrogen Inc.
• Guardant Health Inc.
• Sema4
Regional Dominance: Which Area Leads the Global Genomic Biomarkers Market?
North America was the largest region in the genomic biomarkers market in 2024
